Meta-analysis: rapid infliximab infusions are safe.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 21
- By:
- Publication type:
- Article
Works matching IS 14667401 AND DT 2013 AND VI 14 AND IP 1
Results: 26
1
2
Highlights from Digestive Disease Week 2013.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 33
- By:
- Publication type:
- Article
3
Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 30
- By:
- Publication type:
- Article
4
EVENTS 2013/2014.
- Published in:
- 2013
- Publication type:
- Calendar
5
GPR15-mediated homing controls immune homeostasis in the large intestine mucosa.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 29
- By:
- Publication type:
- Article
6
Effect of polyunsaturated fatty acids on tight junctions in a model of the human intestinal epithelium under normal and inflammatory conditions.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 28
- By:
- Publication type:
- Article
7
The role of the environment in the development of pediatric inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 31
- By:
- Publication type:
- Article
8
A quality improvement project significantly increased the vaccination rate for immunosuppressed patients with IBD.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 31
- By:
- Publication type:
- Article
9
Glucocorticoids alleviate intestinal ER stress by enhancing protein folding and degradation of misfolded proteins.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 29
- By:
- Publication type:
- Article
10
Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 30
- By:
- Publication type:
- Article
11
Serum antibodies associated with complex inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 19
- By:
- Publication type:
- Article
12
Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 27
- By:
- Publication type:
- Article
13
The increasing prevalence of inflammatory bowel diseases among Jewish adolescents and the sociodemographic factors associated with diagnosis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 27
- By:
- Publication type:
- Article
14
The prevalence and outcome of jejunal lesions visualized by small bowel endoscopy in Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 26
- By:
- Publication type:
- Article
15
The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 26
- By:
- Publication type:
- Article
16
Meta-analysis using individual patient data: efficacy and durability of topical alicaforsen for the treatment of active ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 25
- By:
- Publication type:
- Article
17
Are there any differences in the efficacy and safety of different formulations of oral 5-ASA used for induction and maintenance of remission in ulcerative colitis? Evidence from Cochrane reviews.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 24
- By:
- Publication type:
- Article
18
Subcutaneous golimumab induces clinical response and remission in patients with moderate to severe ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 24
- By:
- Publication type:
- Article
19
Early administration of azathioprine versus conventional management of Crohn's disease: a randomized controlled trial.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 23
- By:
- Publication type:
- Article
20
Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 23
- By:
- Publication type:
- Article
21
New and emerging treatments for ulcerative colitis: a focus on vedolizumab.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 22
- By:
- Publication type:
- Article
22
IBD in the Elderly.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 1
- By:
- Publication type:
- Article
23
Safety of thiopurine therapy in inflammatory bowel disease: long-term follow-up study of 3931 patients.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 21
- By:
- Publication type:
- Article
24
When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 20
- By:
- Publication type:
- Article
25
Clinical utility of newly developed immunoassays for serum concentrations of adalimumab and anti-adalimumab antibodies in patients with Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 19
- By:
- Publication type:
- Article
26
Microscopic Colitis: An Updated Review.
- Published in:
- Inflammatory Bowel Disease Monitor, 2013, v. 14, n. 1, p. 12
- By:
- Publication type:
- Article